KBW Downgrades Old Line Bancshares (OLBK), 8 Analysts Are Bullish Achillion Pharmaceuticals, Inc. (ACHN) Last Week

July 17, 2017 - By Adrian Erickson

Among 2 analysts covering Old Line Bancshares (NASDAQ:OLBK), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Old Line Bancshares had 2 analyst reports since November 29, 2016 according to SRatingsIntel. The stock of Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK) earned “Buy” rating by Sandler O’Neill on Wednesday, December 21. Keefe Bruyette & Woods upgraded the stock to “Outperform” rating in Tuesday, November 29 report.

Among 10 analysts covering Achillion Pharma (NASDAQ:ACHN), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Achillion Pharma had 17 analyst reports since August 13, 2015 according to SRatingsIntel. As per Wednesday, September 9, the company rating was initiated by Jefferies. The company was downgraded on Friday, January 29 by Leerink Swann. The firm earned “Market Outperform” rating on Thursday, July 7 by JMP Securities. The stock of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) earned “Buy” rating by Maxim Group on Thursday, February 25. The rating was upgraded by Chardan Capital Markets to “Neutral” on Friday, November 4. Robert W. Baird upgraded Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) on Friday, February 26 to “Outperform” rating. On Wednesday, May 4 the stock rating was maintained by Leerink Swann with “Market Perform”. The company was initiated on Friday, September 23 by Wedbush. Chardan Capital Markets initiated Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) rating on Thursday, July 14. Chardan Capital Markets has “Sell” rating and $4 target. Maxim Group maintained Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) on Thursday, August 13 with “Buy” rating. See Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) latest ratings:

18/05/2017 Broker: Leerink Swann Old Rating: Market Perform New Rating: Outperform Upgrade
02/02/2017 Broker: Ladenburg Thalmann Rating: Buy New Target: $10 Initiate

Investors sentiment decreased to 1.09 in Q4 2016. Its down 0.43, from 1.52 in 2016Q3. It is negative, as 32 investors sold Achillion Pharmaceuticals, Inc. shares while 33 reduced holdings. 22 funds opened positions while 49 raised stakes. 97.41 million shares or 7.54% less from 105.36 million shares in 2016Q3 were reported. Manufacturers Life Insur Com The owns 82,904 shares or 0% of their US portfolio. Swiss Bankshares accumulated 182,400 shares or 0% of the stock. Oxford Asset stated it has 210,165 shares. 13.11M are owned by Orbimed Ltd Llc. Emory University holds 1.85% or 454,102 shares. Bb Biotech Ag holds 1.28 million shares or 0.2% of its portfolio. 13.63M are held by Ra Management Lc. Ameritas Prns Incorporated owns 10,118 shares. National Bank & Trust Of Mellon reported 548,534 shares. Susquehanna Gp Limited Liability Partnership, Pennsylvania-based fund reported 125,828 shares. Connor Clark & Lunn Investment Mngmt Ltd holds 0.01% or 360,849 shares in its portfolio. Vident Invest Advisory has invested 0.04% in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Morgan Stanley reported 2.39 million shares. West Virginia-based City has invested 0% in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Bourgeon Cap Limited Company stated it has 34,500 shares or 0.09% of all its holdings.

It closed at $4.48 lastly. It is down 47.61% since July 17, 2016 and is downtrending. It has underperformed by 64.31% the S&P500.

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $597.84 million. The Firm is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. It currently has negative earnings. The Firm is focused on its complement inhibitor platform, directed at advancing small molecule compounds that have the potential to be used in the treatment of immune-related diseases associated with the alternative pathway of the complement system.

Old Line Bancshares, Inc. is the holding firm of Old Line Bank . The company has market cap of $297.05 million. The Bank is a chartered trust firm engaged in commercial banking business, making various types of loans, investments and accepting deposits. It has a 20.45 P/E ratio. The Bank markets its financial services to small to medium sized businesses, entrepreneurs, professionals, clients and clients.

Since February 7, 2017, it had 9 buys, and 0 selling transactions for $253,247 activity. $28,580 worth of Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK) was bought by Suit John M II. $38,821 worth of Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK) was bought by BURNETT JOSEPH E on Friday, February 24. Semanie Mark A bought $28,000 worth of stock or 1,000 shares. The insider Shah Suhas R bought 870 shares worth $24,554. The insider DENT JAMES F bought 1,500 shares worth $42,106. GRAHAM THOMAS H bought $13,546 worth of stock or 500 shares.

Investors sentiment increased to 2.13 in Q4 2016. Its up 0.63, from 1.5 in 2016Q3. It increased, as 0 investors sold Old Line Bancshares, Inc. (MD) shares while 15 reduced holdings. 12 funds opened positions while 20 raised stakes. 4.96 million shares or 0.44% less from 4.99 million shares in 2016Q3 were reported. Basswood Capital Mgmt Ltd Limited Liability Company invested in 0.35% or 329,118 shares. Banc Funds Ltd Llc owns 499,377 shares for 0.51% of their portfolio. Franklin Res has invested 0% in Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK). Moreover, Fj Capital Ltd Liability has 2.09% invested in Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK). 22,929 were accumulated by Jpmorgan Chase & Company. Tower Rech Lc (Trc) has 0% invested in Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK) for 628 shares. Spark Mngmt Lc holds 0.02% or 12,300 shares. Royal Bank Of Canada stated it has 1,484 shares. Monarch Partners Asset Mngmt Limited Liability Corporation holds 0.04% in Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK) or 18,514 shares. National Bank & Trust Of America Corporation De owns 2,265 shares. California Pub Employees Retirement Systems has 0% invested in Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK). 79,463 are held by Bridgeway Cap. The New York-based Morgan Stanley has invested 0% in Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK). Geode Cap Management Limited Company has 0% invested in Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK). Clarivest Asset Mgmt Llc owns 20,500 shares.

It closed at $27.81 lastly. It is down 54.07% since July 17, 2016 and is uptrending. It has outperformed by 37.37% the S&P500.

Analysts await Old Line Bancshares, Inc. (MD) (NASDAQ:OLBK) to report earnings on July, 19. They expect $0.41 earnings per share, up 46.43% or $0.13 from last year’s $0.28 per share. OLBK’s profit will be $4.38 million for 16.96 P/E if the $0.41 EPS becomes a reality. After $0.36 actual earnings per share reported by Old Line Bancshares, Inc. (MD) for the previous quarter, Wall Street now forecasts 13.89% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: